Results 121 to 130 of about 2,340 (177)
Some of the next articles are maybe not open access.
Indomethacin tocolysis and intraventricular hemorrhage
Obstetrics & Gynecology, 2001To determine the association between indomethacin tocolysis and neonatal intraventricular hemorrhage.Fifty-six preterm neonates with intraventricular hemorrhage were matched by gestational age with neonates (n = 224) without this morbidity. Maternal and neonatal charts were reviewed to ascertain the type of tocolytic exposure experienced by the neonate.
R D, Suarez, W A, Grobman, B V, Parilla
openaire +2 more sources
Prophylactic tocolysis of twins
American Journal of Obstetrics and Gynecology, 1986The prophylactic use of oral terbutaline was studied in 28 normal, healthy, low-risk women with twin gestations. The mean birth weights were significantly increased over those in a similar group of control patients.
openaire +2 more sources
[Tocolysis with clenbuterol tablets]. [PDF]
Zentralblatt fur Gynakologie, 1987 The authors report on the results of treatment of threatening premature labour with clenbuterol. The daily dose was 40 micrograms twice and later 20 micrograms twice with good efficiency. Action of clenbuterol relating to tocolysis, metabolism and cardiovascular system has been compared with fenoterol-perlongettes.
Von Kovacs L +3 more
openaire +1 more source
Clinical Obstetrics & Gynecology, 2014
Preterm birth occurs in 12% of all births in the United States. Preterm labor precedes approximately half of these births. Tocolysis is used in the short term to prolong pregnancy long enough to administer corticosteroids and/or facilitate transfer to a tertiary care center. A number of agents have been used for this therapy, which will be discussed in
openaire +2 more sources
Preterm birth occurs in 12% of all births in the United States. Preterm labor precedes approximately half of these births. Tocolysis is used in the short term to prolong pregnancy long enough to administer corticosteroids and/or facilitate transfer to a tertiary care center. A number of agents have been used for this therapy, which will be discussed in
openaire +2 more sources
Risks and Complications of Tocolysis
Clinical Obstetrics and Gynecology, 1995In this article, the author has reviewed available information on maternal, fetal, and neonatal risks and complications of tocolytic therapy. Because no ideal tocolytic agent exists, clinicians must be aware of the potential problems that can be encountered from initiating tocolysis.
openaire +2 more sources
Current Opinion in Obstetrics and Gynecology, 2004
There is persisting controversy about tocolytic treatment for preterm labour. This review addresses this controversy by appraising the recent clinical literature.Surveys of obstetricians indicate a high usage of tocolysis for preterm labour, but evidence that this treatment confers overall benefit is still lacking.
openaire +2 more sources
There is persisting controversy about tocolytic treatment for preterm labour. This review addresses this controversy by appraising the recent clinical literature.Surveys of obstetricians indicate a high usage of tocolysis for preterm labour, but evidence that this treatment confers overall benefit is still lacking.
openaire +2 more sources
Obstetrics & Gynecology, 2006
Intravenous magnesium sulfate tocolysis remains a North American anomaly. This therapy rose to prominence based on poor science and the recommendations of authorities. However, a Cochrane systematic review concluded that magnesium sulfate is ineffective as a tocolytic. The review found no benefit in preventing preterm or very preterm birth.
David A, Grimes, Kavita, Nanda
openaire +2 more sources
Intravenous magnesium sulfate tocolysis remains a North American anomaly. This therapy rose to prominence based on poor science and the recommendations of authorities. However, a Cochrane systematic review concluded that magnesium sulfate is ineffective as a tocolytic. The review found no benefit in preventing preterm or very preterm birth.
David A, Grimes, Kavita, Nanda
openaire +2 more sources
Indomethacin Tocolysis and Neurodevelopmental Outcome
The Indian Journal of Pediatrics, 2011To compare the neurodevelopmental outcomes, at 30-42 months adjusted age, between infants exposed to antenatal indomethacin and those unexposed to antenatal indomethacin.This was a retrospective cohort study. The study cohort consisted of all nonanomalous infants with birth weight ≤ 1250 g and/or gestational age ≤ 28 wks born between 2000 and 2003, who
Amuchou S, Soraisham +2 more
openaire +2 more sources
The controversy surrounding indomethacin for tocolysis
American Journal of Obstetrics and Gynecology, 2001Indomethacin is a prostaglandin synthetase inhibitor sometimes used for tocolysis. Several placebo-controlled trials and trials comparing indomethacin to other potential first-line tocolytic agents support its efficacy for delaying delivery for >48 hours.
G A, Macones +3 more
openaire +2 more sources
Hemodynamic effects of nifedipine tocolysis
Journal of Obstetrics and Gynaecology Research, 2014AbstractAimTo describe the effects of nifedipine tocolysis on blood pressure and heart rate in non‐hypertensive women.MethodsThis was a retrospective study from 2001 to 2011 to compare blood pressures and heart rates among non‐hypertensive women on nifedipine tocolysis up to 8 h after nifedipine initiation.
Kelly, Yamasato +2 more
openaire +2 more sources